Anti-inflammatory and cytostatic activities of a parthenolide-like sesquiterpene lactone from Cota palaestina subsp. syriaca
Loading...
Files
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Hindawi Limited
Abstract
A sesquiterpene lactone 1-β,10-Epoxy-6-hydroxy-1,10H-inunolide (K100) was isolated through bioassay-guided fractionation from Cota palaestina subsp. syriaca, an Eastern Mediterranean endemic plant. K100 inhibited endotoxin- (ET-) induced proinflammatory markers: IL-6, MMP-9, and NO in normal mouse mammary SCp2 Cells. Molecular docking in silico suggested that K100, having highly analogous structure as parthenolide (PTL), an anticancer compound, could bind PTL target proteins at similar positions and with comparable binding affinities. Both compounds, K100 and PTL, inhibited the proliferation and prolonged the S-phase of the cell cycle of breast adenocarcinoma MDA-MB-231 cells grown in 2D cultures. Noncytotoxic concentrations of K100 and PTL decreased the proliferation rate of MDA-MB-231 and shifted their morphology from stellate to spherical colonies in 3D cultures. This was accompanied with a significant increase in the amount of small colonies and a decrease in the amount of large colonies. Moreover, K100 and PTL decreased cellular motility and invasiveness of MDA-MB-231 cells. In summary, these results suggest that K100 exhibits PTL-analogous anti-inflammatory, cytostatic, and antimetastatic effects. © 2015 Rabih S. Talhouk et al.
Description
Keywords
1 beta,10 poxy 6 hydroxy 1,10h inunolide, Antiinflammatory agent, Antineoplastic agent, Endotoxin, Gelatinase a, Gelatinase b, Interleukin 6, Nitric oxide, Parthenolide, Sesquiterpene lactone, Unclassified drug, Animal cell, Antiinflammatory activity, Antineoplastic activity, Antiproliferative activity, Article, Asteraceae, Breast epithelium cell, Carcinoma cell, Cell cycle progression, Cell motility, Computer model, Controlled study, Cota palaestina, Cytokine production, Drug identification, Drug mechanism, Drug structure, Extracellular matrix, Human, Human cell, Molecular docking, Mouse, Nonhuman, Phenotypic variation, Priority journal, Protein expression